Sector: MedicalINFINITY PHARMACEUTI (NASDAQ: INFI)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 284 |
Technical : | 206 |
Performance : | 267 |
Overall: | 292 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 287 |
Technical : | 264 |
Performance : | 269 |
Overall: | 301 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 284 |
Technical : | 54 |
Performance : | 281 |
Overall: | 255 |
Number of Stocks: | 306 |
Headlines
- Guard Dog Brand Development Receives Three Silver Davey Awards in the Corporate Identity Category in the 5th Annual International Davey Awards for 2009
Nov 18, 2009 01:01 PM | INFI
- Infinity's IPI-504 Named One of Windhover and Campbell Alliance's "Top 10 Projects to Watch" in Oncology
Nov 17, 2009 08:03 AM | INFI
- Adelene Q. Perkins Named "Best Executive" at Annual Stevie(R) Awards Ceremony
Nov 16, 2009 09:31 AM | INFI
- Infinity to Present at Upcoming Conferences
Nov 10, 2009 07:32 AM | INFI, PJC
- Infinity Reports Recent R&D Highlights and Third Quarter 2009 Results
Nov 09, 2009 04:03 PM | INFI
- Infinity Announces Third Quarter 2009 Results Conference Call
Nov 02, 2009 06:31 AM | INFI
- CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals
Oct 28, 2009 07:35 AM | BMY, INFI
- Griffin Securities Announces Investment Opinion on Targeting Cancer Stem Cells
Oct 09, 2009 09:11 AM | BMY, CRIS, EXEL, INFI, KERX
- Infinity Announces Appointment of Dr. Thomas J. Lynch to Its Board of Directors
Oct 07, 2009 07:01 AM | INFI
- StockPreacher.com Issues Trading Overview for Oncolytics Biotech Inc.
Oct 07, 2009 06:52 AM | AGEN, ARQL, INFI, ONCY, SUPG
- Infinity Reports Recent R&D Highlights and Second Quarter 2009 Results
Aug 05, 2009 04:16 PM | INFI
- Infinity Announces Second Quarter 2009 Results Conference Call
Jul 30, 2009 06:31 AM | INFI
- Infinity Paper On Discovery of Its Novel Hedgehog Inhibitor, IPI-926, Published in Journal of Medicinal Chemistry
Jul 23, 2009 04:41 PM | INFI
- Infinity Pharmaceuticals Added to Russell 2000(r) Index
Jun 29, 2009 06:30 AM | INFI
- Infinity Reports Encouraging Clinical Data for IPI-504 at ASCO 2009
May 30, 2009 02:00 PM | INFI
- New Paper in Science Features Infinity's IPI-926 Hedgehog Pathway Inhibitor as a Promising New Approach in Chemo-Resistant Pancreatic Cancer
May 29, 2009 06:30 AM | INFI
- Infinity Pharmaceuticals Named Winner of The Scientist's 'Best Places to Work in Industry' and Featured in Boston Business Journal's Best Places to Work 2009 Survey
May 27, 2009 01:01 PM | INFI
- Clinical Data From Infinity's Hsp90 Chaperone Inhibitor Program to be Presented During ASCO Meeting
May 13, 2009 07:30 AM | INFI
- Infinity Reports Recent Pipeline Developments and First Quarter 2009 Results
May 04, 2009 04:30 PM | INFI
- Infinity Announces First Quarter 2009 Results Conference Call
Apr 28, 2009 10:01 AM | INFI
- Form 4 Lynch Thomas J. Jr. For: Oct 06 (10K)
Oct 08, 2009 11:54 AM
- Form 3 Lynch Thomas J. Jr. For: Oct 06 (10K)
Oct 08, 2009 11:54 AM
- Form 4 LANDER ERIC S For: Jun 17 (10K)
Jun 19, 2009 06:18 PM
- Form 4 EVNIN ANTHONY B For: Jun 17 (10K)
Jun 19, 2009 04:26 PM
- Form 4 VENUTI MICHAEL C For: Jun 17 (10K)
Jun 19, 2009 03:20 PM
- Form 4 SMITH IAN F For: Jun 17 (10K)
Jun 19, 2009 03:20 PM
- Form 4 TANANBAUM JAMES B For: Jun 17 (10K)
Jun 19, 2009 03:20 PM
- Form 4 LEVINE ARNOLD J For: Jun 17 (10K)
Jun 19, 2009 03:18 PM
- Form 4 Lee Patrick Pak-Tin For: Jun 17 (10K)
Jun 19, 2009 03:18 PM
- Form 4 Babler Martin For: Jun 17 (10K)
Jun 19, 2009 03:17 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
INFI
|
Compare to S&P
|
| YTD |
-25.53 %
|
-38.37 %
|
| 4 Weeks |
-0.67 %
|
-1.74 %
|
| 12 Weeks |
-17.59 %
|
-22.31 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 28.00 %
|
|
EPS Growth in Last Year: 42.86 %
|
|
Sales Growth in Last Quarter: 4.64 %
|
|
Sales Growth in Last Quarter: 451.04 %
|
|
